OKYO Pharma Limited
OKYO
$2.42
$0.052.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.01M | -1.01M | -1.34M | -1.34M | -4.00M |
| Total Depreciation and Amortization | 700.00 | 700.00 | 600.00 | 600.00 | 900.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 628.20K | 628.20K | 4.90K | 4.90K | 2.05M |
| Change in Net Operating Assets | -400.40K | -400.40K | 1.21M | 1.21M | 607.10K |
| Cash from Operations | -784.80K | -784.80K | -120.70K | -120.70K | -1.35M |
| Capital Expenditure | -600.00 | -600.00 | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -600.00 | -600.00 | -- | -- | -- |
| Total Debt Issued | 474.10K | 474.10K | 900.00 | 900.00 | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 577.90K | 577.90K | 275.00K | 275.00K | 1.10M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.05M | 1.05M | 275.90K | 275.90K | 1.10M |
| Foreign Exchange rate Adjustments | 20.30K | 20.30K | -75.10K | -75.10K | -150.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 286.90K | 286.90K | 80.20K | 80.20K | -395.30K |